Chapter 29: Endocrine and Metabolic Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we talk about a person's metabolism, we kind of think of it like a car running on cruise control.

Right, yeah.

Like blood sugar goes up after a meal and then insulin steps in to bring it down and everything just hums along smoothly.

It's normally a highly predictable system.

It really is.

I mean, it's a beautifully balanced system of supply and demand, and it's completely designed to keep your body in, you know, perfect homeostasis.

Right, but then you introduce pregnancy into the mix and suddenly that reliable cruise control system is just, it's thrown completely out the window.

Oh, absolutely.

Because you've got this newly formed organ, right, the placenta, and it's basically hijacking the steering wheel.

And it only has one single goal, which is to feed the baby at all costs, regardless of what it actually does to the mother's baseline metabolism.

Exactly.

It really is a complete metabolic rewiring.

Like the physiological adaptations required just to maintain a normal, healthy pregnancy

are, frankly,

staggering when you look at them on a cellular level.

They really are.

So welcome to the deep dive.

If you are a nursing student and you're staring down chapter 29 of maternity and women's health care, the endocrine and metabolic disorders chapter, just take a deep breath.

We got you.

We do.

We are your last minute lecture team.

And today we are not just going to like memorize a list of complications.

We're going to understand the why behind them.

Yeah, that foundational understanding is so key.

Right.

So we're starting with how pregnancy completely rewires a woman's metabolism and we'll go all the way through managing gestational diabetes, hyperemesis, and even thyroid disorders.

Okay, let's unpack this.

So to really grasp how endocrine disorders complicate a pregnancy, we first have to establish what a normal pregnancy looks like metabolically.

The baseline.

Exactly.

And everything we talk about today really hinges on one fundamental, unbreakable rule.

And that is glucose crosses the placenta,

but insulin does not.

I feel like that is the golden rule for this entire topic.

It really is.

So the glucose crosses over to the baby via carrier -mediated facilitated diffusion.

So whatever the mom's blood sugar level is at any given moment, the fetus's level is directly proportional to it.

Yes, proportional.

So keeping that golden rule in mind, let's look at the first trimester.

A pregnant woman's body is flooded with rising levels of estrogen and progesterone.

And we often think of these as just reproductive hormones, but they actually stimulate the beta cells in the mother's pancreas, which prompts them to increase insulin production.

Oh, wow.

Yeah.

And at the same time, her peripheral tissues actually increase their sensitivity to insulin.

And the whole point of this is to help build up energy stores for the baby later on.

So wait, she is making more insulin and her body is using it more efficiently?

Exactly.

Which means her fasting blood glucose levels actually drop by like about 10 % compared to her pre -pregnancy baseline.

Right.

And clinically, that drop is highly significant.

Because for a woman who enters pregnancy with pre -existing insulin -dependent diabetes, this physiological shift makes her incredibly prone to hypoglycemia during that first trimester.

That makes total sense.

Her body is suddenly hyper -efficient at clearing glucose from the bloodstream.

Yep.

And if she's also dealing with, you know, the classic nausea and vomiting of early pregnancy, she probably isn't taking in enough carbohydrates to balance that hyper -efficiency out.

Oh, man.

Yeah.

But then as we move into the second and third trimesters, the script completely flips, right?

Like the textbook actually calls this the diabetogenic effect of pregnancy.

It does.

Because as the placenta grows and matures, it starts secreting massive amounts of its own hormones.

The bouncers?

Yeah.

Specifically, human chorionics, metamamotropin, cortisol, and an enzyme called insulinase.

And together, these act as really potent insulin antagonists.

I always picture these placental hormones as massive, intimidating bouncers at a nightclub.

I love that analogy.

Right.

Because the maternal insulin is trying to escort glucose out of the bloodstream and into the maternal cells.

But the placental bouncers step in, cross their arms, and say, nope, not tonight.

Exactly.

They physically block the insulin from doing its job.

Which creates this profound insulin resistance in the mother's tissues.

And they do this so that the absolute VIP, the fetus, gets an abundant, uninterrupted supply of circulating glucose.

That is a brilliant way to visualize it.

It is entirely a glucose -sparing mechanism for the baby.

Wow.

And if we connect this to the bigger picture,

this physiological rollercoaster is the exact reason why a patient with pre -existing diabetes is going to need constant, meticulous insulin dose adjustments.

Right.

Because the needs are changing so fast.

Exactly.

If you look at figure 29 .1 in your chapter, which graphs changing insulin needs, you clearly see that initial dip in the first trimester.

But then, right around weeks 18 to 24, those needs begin to climb steeply.

Yeah.

I was looking at that graph, and the text notes maternal insulin requirements might double or even quadruple by 36 weeks just to overcome those placental bouncers.

It's a massive shift.

And then,

the moment of birth changes everything again.

Right.

Because the placenta is gone.

Precisely.

The physical delivery of the placenta abruptly removes the source of those insulin antagonists.

The bouncers are suddenly fired.

Ha!

Fired immediately.

So maternal insulin needs plummet back to pre -pregnancy levels almost immediately.

Furthermore, if the mother chooses to breastfeed, her insulin needs drop even lower because the physiological process of lactation actively consumes maternal glucose.

That is a great baseline to work from.

We know what's supposed to happen.

So let's look at what happens when the mother's pancreas simply cannot keep up with that massive escalating demand for insulin.

Yeah.

Let's talk about the pathogenesis of diabetes mellitus.

So fundamentally, when insulin is insufficient or completely ineffective, glucose cannot enter the muscle and adipose cells.

So it just builds up in the bloodstream, creating severe hyperglycemia.

Right.

And now, this isn't just about high numbers on a monitor.

This hyperglycemia actually causes hyperosmolarity of the blood itself.

It makes the blood thick and syrupy.

Exactly.

And because of osmosis, that hyperosmolar, thick blood begins pulling intracellular fluid out of the body's cells and into the vascular system to dilute the sugar.

Oh, jeez.

So the cells themselves become profoundly dehydrated while the blood volume rapidly expands.

And the kidneys detect this, right?

Yes.

The kidneys detect this massive volume of fluid and unusable glucose, and they just go into overdrive to excrete it.

This is the physiological mechanism behind polyuria or frequent urination.

And because the patient is peeing out all their vital fluid, they develop polydipsia, which is excessive thirst.

Right.

Meanwhile, on a cellular level, the body is literally starving because the cells can't access the glucose that's trapped in the bloodstream.

So the brain triggers polyphagia, excessive hunger.

It's a vicious cycle.

And to survive this perceived starvation, the body shifts to burning fat and muscle for energy.

Which is really dangerous.

Very.

The metabolic byproduct of breaking down all that fat is ketones.

These accumulate in the blood and eventually lead to ketoacidosis, which is a life -threatening state.

Knowing how destructive that process is, let's look at how we classify it.

Because nursing exams absolutely love table 29 .1, White's classification of diabetes in pregnancy.

Oh, they do.

The textbook divides this into gestational diabetes, which is classes A1 and A2.

A1 is diet controlled, A2 requires medication.

Then you have pregestational diabetes, which covers classes B through T.

The crucial element for a nursing student to recognize here is the concept of disease progression.

Right.

Classes B, C, and D categorize patients based on the age they were diagnosed and the duration of the disease.

But once a patient moves into class F, R, or T, the classification is no longer just about time.

So what is it about?

It indicates serious, irreversible vascular complications.

So wait, when a nurse looks at a chart and sees a patient labeled like class F or class R, that immediately signals that end organ damage is already in play.

Precisely.

Class F indicates nephropathy, meaning the tiny blood vessels in the kidneys are damaged.

And class R indicates retinopathy, meaning the blood vessels in the eyes are damaged.

Seeing those letters instantly alerts the interprofessional team that this patient's microvascular system is heavily compromised.

Which severely elevates her risk for major complications like preeclampsia as the pregnancy progresses.

Exactly.

That perfectly transitions us to the actual risks and complications of pregestational diabetes.

The maternal risks are incredibly intense.

They really are.

The text notes that poor glycemic control, especially later in pregnancy, leads to fetal macrosomia, which is a birth weight over 4 ,000 to 4 ,500 grams.

And macrosomic infants tend to have a disproportionate increase in shoulder and chest size, right?

They do.

And that specific anatomy creates a terrifying risk for shoulder dystocia during a vaginal delivery.

That's where the baby's head emerges, but the shoulders get stuck behind the maternal pubic bone.

Right.

It's an emergency.

This is exactly why mothers with poorly controlled diabetes often require a planned cesarean birth.

The book also says these mothers are at high risk for hydromneos, which is an excess of amniotic fluid over 24 centimeters.

But I couldn't quite connect the dots on why high maternal blood sugar causes extra amniotic fluid in the uterus.

Like, how does that actually work?

It comes right back to the golden rule.

Glucose crosses the placenta.

Oh, right.

Yeah.

So maternal hyperglycemia causes fetal hyperglycemia.

The baby's blood sugar spikes, which induces fetal polyuria.

Wait, the baby pees more?

Exactly.

The baby is essentially experiencing the same frequent urination we see in adult diabetics, peeing excessive volumes of fluid directly into the amniotic sac, causing it to overfill.

That is fascinating.

So it's literally fetal urine.

Yep.

The mothers are also at high risk for infections like UTIs and mannilial vaginitis.

Because altered carbohydrate metabolism disrupts leukocyte function and changes the vaginal pH?

Which is a huge problem.

Yeah.

And I want to highlight something huge here.

Any infection severely increases the risk for diabetic ketoacidosis, or DKA.

But the textbook points out that DKA in pregnancy happens at much lower blood glucose levels, barely exceeding 200 milligrams per deciliter.

Right.

Why doesn't it take levels of 300 or 400 like in a non -pregnant person?

It's because of the baseline metabolic stress of pregnancy.

Between the heavy demands of the growing fetus and the insulin resistance caused by placental hormones,

a pregnant woman's body is already primed to rely on fat stores for energy much faster than a non -pregnant person.

Ah, I see.

So if you add the stress of an infection, which spikes cortisol and further blocks insulin, her body tips into burning fat and producing ketones incredibly fast.

She drops into metabolic acidosis at a fraction of the blood sugar level you might expect.

And DKA in pregnancy can quickly lead to intrasodder and fetal death.

That is terrifying.

Now, let's look at the fetal risks.

Hyperglycemia during the first trimester when the baby's organs are actively forming is the main cause of birth defects, particularly cardiac and central nervous system anomalies.

Which is why early control is so vital.

But wait, hold on.

I'm looking at table 29 .2 and I'm really confused.

If the mom is walking around hyperglycemic with dangerously high blood sugar, why on earth is the newborn at risk for a massive blood sugar crash, hyperglycemia, the second it's born?

That feels totally backward.

It definitely seems counterintuitive until you look closely at the fetal pancreas.

Okay, wait on me.

Around 10 to 14 weeks of gestation, the fetal pancreas begins to function.

It senses this massive sugar load coming from the mother and in response secretes massive amounts of its own insulin to handle it.

Oh, wow.

Yeah, this creates a state of fetal hyperinsulinism.

And since insulin acts like a growth hormone for the fetus, that massive insulin production is what causes the baby to get so huge, the macrosomia.

Exactly.

But then, birth happens.

The cord is clamped.

Right.

The mother's endless sugar supply is instantly severed.

However, the baby's pancreas is still churning out massive amounts of insulin based on the previous environment.

Because it hasn't caught up to the new reality yet.

Yep.

That excess insulin suddenly has no maternal sugar to work on, which causes a rabid dangerous blood sugar crash in the neonate shortly after delivery.

Boom.

That makes perfect sense when you actually understand the mechanism.

So how do we manage all of this?

Well, at the first prenatal visit for a patient with pregestational diabetes,

the nurse is doing a massive workup.

Right.

One key test is the hemoglobin A1C, which gives a sort of report card of glycemic control over the past two to six weeks.

But there is a glaring red nursing alert box right next to this in the text regarding anemia.

The alert states that iron deficiency anemia falsely increases the A1C level in pregnancy.

Wait.

Really?

Why?

The reason why is crucial for clinical reasoning.

The A1C test measures the percentage of glucose attached to the hemoglobin of red blood cells over the cell's lifespan.

Okay.

Tracking.

If a patient has iron deficiency anemia, the normal turnover rate of her red blood cells is altered.

The cells live longer in circulation, accumulating more sugar over time, which gives a falsely elevated A1C reading.

Oh, that's wild.

So you must check their iron status to interpret the A1C accurately.

That is such a good NCLEX trap.

So the targets are strict.

Table 29 .3 outlines that we want fasting levels between 60 and 95 milligrams per deciliter, one hour post meal under 140, two hour post meal under 120.

Very strict.

To get there, they need a diet focused on complex carbs and regular exercise.

But another nursing alert pops up here.

They must stop exercising immediately if uterine contractions occur.

Yes, very important.

We also rely heavily on insulin therapy.

Most women with pre -gestational type 1 diabetes will be on multiple daily injections.

And table 29 .4 along with the teaching boxes get incredibly specific about how to mix these insulins in a single syringe saying, we have to draw the clear before cloudy.

Right, clear before cloudy.

Why does the order matter so much?

It's a great question.

The cloudy insulin is NPH,

or neutral protamine hagedorn.

It's cloudy because it contains specific proteins that deliberately slow down its absorption, making it an intermediate acting insulin.

The clear insulin is your rapid acting type, like Luspro or Aspart.

You inject air into the NPH vial first, then air into the clear rapid acting vial.

You leave the needle in the clear vial, draw up your rapid dose, then move to the cloudy NPH vial to drop the rest.

Okay, but why clear first?

The reason you draw clear before cloudy is to prevent contaminated the rapid acting vial with the NPH proteins.

Oh, I see.

Yeah.

If even a tiny drop of cloudy NPH gets into the clear vial, it alters the action time of that entire rapid acting vital, which could literally ruin the patient's fast acting dose later on.

Okay, that is super important.

Now during the interpartum period actual labor, we start a maintenance IV of normal saline.

But once active labor hits, or if the mother's glucose falls below 70, we switch that IV to a 5 % dextrose solution.

We monitor blood sugar hourly, targeting less than 110.

But looking at the teaching boxes for home care, I want to highlight something critical.

What if the patient has a severe hypoglycemic episode at home where they are unconscious or physically can't swallow?

If they are unconscious, giving them oral glucose is an extreme choking hazard.

Please don't do that.

Yeah, definitely not.

The emergency protocol here is 50 % dextrose given via IV push.

Or if you don't have IV access in a home setting,

1mg of glucagon given intramuscularly.

And postpartum, the nurse needs to teach the breastfeeding mother that milk production physically uses up glucose from her bloodstream.

So her insulin needs drop even lower, putting her at high risk for hypoglycemia right after feeding the baby.

That covers pre -existing conditions pretty well.

But let's shift to a condition that originates entirely from the pregnancy itself.

Gestational diabetes mellitus.

Exactly.

GDM.

This is carbohydrate intolerance that develops or is first recognized during the pregnancy, usually diagnosed in the second or third trimester.

Right.

Because that's when those placental bouncers really start flexing and causing severe insulin resistance.

Yep.

The bouncers arrive.

And since GDM develops after the first trimester, after the baby's organs are already formed,

there is no increased risk for major structural birth defects.

That's a huge relief for patients.

But the risk for fetal macrosomia is still huge, and that there's a 70 % risk the mother will go on to develop type 2 diabetes later in life.

Right.

And there is a massive debate in the evidence -based practice box regarding how we actually screen for GDM.

Oh, yeah.

Figure 29 .5 shows a two -step method, and 29 .6 shows a one -step method.

You have two competing organizations with two completely different algorithms.

Right.

You've got the ACOG method versus the IAD PSG method.

What is actually going on here?

Let's unpack those acronyms first.

ACOG is the American College of Obstetricians and Gynecologists.

They advocate for a two -step method.

Step one is a 50 -gram oral glucose screen, and no fasting is required.

If the blood draw an hour later is elevated, usually over 130 or 140, the patient moves to step two.

And step two is brutal.

It is.

Step two is a grueling 100 -gram glucose drink, required fasting, with blood drawn over three hours.

A diagnosis of GDM requires two out of four of those values to be elevated.

Contrast that with the other group, the IAD PSG, the International Association of Diabetes and Pregnancy Study Groups.

They recommend skipping straight to a one -step method.

It's a 75 -gram, two -hour fasting oral glucose tolerance test.

And if even one single value is elevated, the patient is diagnosed with GDM.

That's right.

The analogy I use here is phishing.

The ACOG two -step method is like using a wide net to catch suspicious fish, then putting them in a smaller net to carefully confirm if they are actually the fish you want.

Nice.

The one -step method is just throwing a super fine net that catches absolutely everything at once.

And that super fine net is exactly why the debate exists.

The one -step method diagnoses significantly more women with GDM.

Which sounds good, right?

Well, while catching more cases sounds good, it means more medical treatment, more intense monitoring, much higher anxiety for the mother, and it costs the health care system a tremendous amount of money.

Oh, I see.

Yeah.

ACOG argues there simply isn't enough hard evidence that the one -step method significantly improves long -term clinical outcomes to justify labeling so many women as high -risk.

That is a classic NCLEX unfolding case study topic right there.

Recognizing that GDM puts the infant at risk for macrosomia and hypoglycemia, regardless of which algorithm the hospital uses to diagnose it.

Absolutely.

So how does a nurse's care plan for GDM differ from pre -gestational diabetes?

Well, the first -line treatment for GDM is always lifestyle modification.

Diet and moderate exercise, roughly 30 minutes a day, 5 days a week.

If pharmacology is needed, the American Diabetes Association still prefers insulin as the gold standard.

But the text specifically notes that oral agents like metformin and gliboride are heavily used in practice, even though they lack FDA approval for this specific use and they actually

It's true.

It's a bit of a gray area.

Metformin works by decreasing hepatic glucose production, and gliboride stimulates the maternal pancreas to release more insulin.

So why use them if they aren't FDA approved for this?

Providers often prescribe them because a simple pill is far easier for patients to comply with than daily injections.

However, because they cross the placenta and we still lack comprehensive long -term neonatal safety data,

insulin remains the safest, most studied option.

And what happens postpartum for these GDM moms?

They need to be rescripted at 6 to 12 weeks with a 75 -gram oral glucose tolerance test to make sure their metabolism resets, right?

And then they need screening every three years for the rest of their lives.

This brings up a critical patient education moment for the nurse.

You must hammer home to these patients that developing type 2 diabetes later in life is not an inevitable destiny.

Lifestyle changes made in the postpartum period, diet, exercise, weight loss, are deeply preventative and can absolutely change their long -term trajectory.

Let's move away from glucose entirely and look at a totally different metabolic and GI disruption, hyperemesis gravidarum.

We all know nausea and vomiting of pregnancy or NVP is normal, but hyperemesis is extreme.

It's defined by a weight loss of more than 5 % of their pre -pregnancy weight, severe dehydration, electrolyte imbalances, and most importantly, ketonuria.

Ketonuria is the primary red flag.

The very first thing the nurse should assess when a patient presents with severe vomiting is a urinalysis for ketones.

Okay, why ketones specifically?

If ketones are present, it proves the mother's body is literally in a state of starvation and has resorted to breaking down fat stores for baseline survival.

Wow.

So for care management, IV fluids are always the first priority to correct the profound dehydration.

Always.

Then we look at medications.

The first line pharmacological recommendation is Dicledgis or Bongesta, which is a combination drug of vitamin B6, also known as pyridoxin, and doxylamine.

If that fails, we might step up to dopamine antagonists like promethazine or GI motility agents like metoclopramide to help empty the stomach faster.

And what about diet?

The teaching box on diet is crucial here.

Once the patient can actually tolerate food,

the nurse must teach them to separate their liquids from their solids.

Like don't drink water while eating a meal.

Exactly.

Do not drink water and eat a meal at the same time, because it overfills the stomach and triggers the gag reflex.

Try the sweet and salty approach.

Ginger tea works wonders.

Or sucking on a popsicle if even the feeling of an empty stomach makes them vomit.

From a nursing perspective, we really have to consider what this means for the patient's daily life.

It means providing deeply compassionate, non -judgmental care.

Hecarimesis is physically and emotionally debilitating.

It is not just morning sickness.

Some of these women are hospitalized for weeks and end up needing enteral tube feedings just to survive the pregnancy.

It is a brutal condition that requires immense nursing support.

Finally, let's wrap up with two specific endocrine conditions where the mother's strict adherence to treatment literally dictates the baby's brain development.

Thyroid disorders and PAH deficiency.

Okay, first, hyperthyroidism, which in pregnancy is usually caused by Graves' disease.

Treatment here requires a delicate balancing act with medications.

It does.

In the first trimester, we use a drug called PTU or propylthia or CIL.

We have to use PTU early on because the standard alternative drug, methamazole, often abbreviated as MMI, is linked to severe facial and esophageal anomalies if the fetus is exposed to it during that critical first trimester organogenesis.

But wait, PTU carries a black box warning because it can cause severe liver toxicity?

Yes.

It's a calculated trade -off.

So as soon as the first trimester is over, the provider will switch the patient to methamazole to save the liver.

Exactly.

And the big nursing alert here, watch for a thyroid storm.

It can be triggered by the extreme physical stress of labor, presenting suddenly with high fever, severe tachycardia, and restlessness.

On the flip side, we have hypothyroidism, which is usually caused by Hashimoto's thyroiditis.

This is treated with synthetic thyroid hormone, levothyroxine.

And here is a critical medication alert that connects directly to pathophysiology.

Levothyroxine must be taken at least four hours apart from iron supplements.

Let's focus on why this matters so much.

Ferrous sulfate, the iron and prenatal vitamins, physically binds to levothyroxine in the GI tract.

Okay.

It creates an insoluble complex that the body just can't absorb, it just passes through the gut.

Why is that so terrifying?

Because the fetal brain depends completely on maternal T4 thyroid hormone until about 12 weeks of gestation when the fetal thyroid finally kicks in.

Exactly.

If the mom's T4 drops because she took her medication with her prenatal vitamin, the neurological consequences for the baby's developing brain can be devastating and permanent.

It is a perfect example of how clinical reasoning connects basic pharmacology to high stakes patient teaching.

The nurse's education literally protects the fetal brain.

Lastly, we have PAH deficiency, which stands for phenylenine hydroxylase deficiency, more commonly known as PKU.

This is an inborn genetic inability to metabolize phenylenine, which is an essential amino acid found in all dietary protein.

The toxic buildup of this amino acid in the blood causes severe cognitive impairment.

The absolute key for a nurse to know here is that strict dietary restriction of phenylenine must begin before conception.

Wow, before conception.

Yes.

The target level is two to six milligrams per deciliter.

If the mother's levels are uncontrolled and high during pregnancy, the baby will suffer from microcephaly, intellectual disability, and severe congenital cardiac anomalies.

And just a quick note on postpartum care for these mothers, breastfeeding is totally safe for a mom with PKU unless the infant has also been tested and diagnosed with PKU.

Right.

So if we summarize the incredible journey we've taken today, we started with the normal physiological insulin resistance caused by placental hormones.

The bouncers, yep.

We mapped how that exact mechanism sensed the stage for diabetes, the severe risks of fetal macrosomia and DKA, and the intricacies of insulin management.

We navigated the great GDM screening debate between ACOG and IADPSG.

The fishing nets.

Exactly.

And we laid out the strict protocols required to keep mothers and babies safe in the face of hyperemesis, thyroid dysfunction, and PKU.

It is a lot of information to hold in your head, but if you remember the underlying mechanism, the why then nursing interventions fall right into place.

But before we go, I want to leave you with a thought to ponder.

We talked heavily about how rigid and generalized our screening algorithms are right now, like that ACOG two -step oral glucose tolerance test.

But as continuous glucose monitors, CGMs become cheaper and more integrated with AI and closed -loop insulin pumps.

Well, how long will it be before those generalized one -size -fits -all tests are completely replaced by entirely personalized real -time metabolic profiling during pregnancy?

It's a fascinating horizon.

I mean, the medical technology is advancing so rapidly that it's outpacing the clinical guidelines.

We might see a total paradigm shift in how we monitor maternal metabolism in the next decade.

It really is incredible to think about.

Remember at the start, we talked about pregnancy throwing the metabolic cruise control completely out the window?

Well, someday soon, AI and CGMs might just build a better autopilot for these mothers.

From the Last Minute Lecture Team, thank you so much for joining us for this deep dive into Chapter 29.

We are rooting for you.

We wish you the absolute best of luck on your exams, and we will see you out there in clinicals.